Supplementary Notes: M--Males; F--Females; n--Sub-sample size; SD--Standard deviation.
Supplementary Notes: (1)In the EU longevity GWAS, "+" means the allele is more frequent in individuals >=90 years of age as compared to individuals <65 years of age, while "-" means the opposite. (2) NA; not available, MAF; minor allele frequency.(3) rs1487615 and rs11652197 were used as proxy SNPs for rs1487614 and rs7213812 with r 2 = 1 and r 2 = 0.97, respectively, in the columns of EU longevity GWAS (according to the database, http://snipa.helmholtz-muenchen.de/snipa/index.php?task=proxy_search), since the SNPs of rs1487614 and rs7213812 were not available in the EU longevity GWAS. For the other SNPs which were not available (marked as "NA") in the EU longevity GWAS and/or New England GWAS, we did not find the proxy SNPs with r 2 >0.8 using the database. Note: For these 14 SNPs in the TOMM40-APOE-APOC1 region that were significantly associated with longevity in both our GWAS and previously reported studies, we conducted a haplotype analysis in which the haplotype blocks were defined on the basis of the method of reference [3] and visualized using Haploview [4] . IL6,CXCL13,TNFRSF10C,BMPR1A,TNFRSF11B,IL2RB,VEGFA,GHR,  TNFRSF1B,TNFSF13B,IL15RA, IL1RAP,GF,  TNFRSF21,PLEKHO2,TGFB2, 
Supplementary

References
